BioInfra Life Science Inc. Logo

BioInfra Life Science Inc.

Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.

266470 | KO

Overview

Corporate Details

ISIN(s):
KR7266470004
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산로9길 66 제1동 712호(가산동, 더리즌밸리지식산업센터), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioInfra Life Science Inc. is a global healthcare and biotechnology company specializing in oncology. The company focuses on cancer prevention and early detection through its proprietary Multi-Biomarker Blood Test, a technology developed over more than 15 years of research that analyzes a small blood sample to assess the risk for eight major cancers. In addition to diagnostics based on protein chip technology, BioInfra is engaged in the research and development of cancer gene treatments, localized drug delivery systems, and technologies to monitor metastasis and recurrence. Established in 2001, the company aims to improve cancer survival rates through innovative healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.7 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.4 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.6 KB
2025-03-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.5 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 10.3 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 908.7 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 91.1 KB
2025-02-28 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 14.7 KB
2024-12-20 00:00
Regulatory News Service
불성실공시법인지정 (공시불이행)
Korean 4.7 KB
2024-12-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 52.7 KB
2024-12-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 52.6 KB
2024-12-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-06 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.1 KB

Automate Your Workflow. Get a real-time feed of all BioInfra Life Science Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioInfra Life Science Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioInfra Life Science Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.